Nutanix Rises on Strong Earnings and Institutional Buys Despite 473rd Trading Volume Rank and Insider Sales

Generated by AI AgentAinvest Volume Radar
Thursday, Sep 4, 2025 6:20 pm ET1min read
Aime RobotAime Summary

- Nutanix (NTNX) rose 1.13% on Sept 4, 2025, with $0.22B volume and 473rd market activity rank.

- Institutional investors increased stakes (Magnetar, Stifel), while Q2 revenue grew 19.2% and EPS beat forecasts.

- Analyst ratings split (Susquehanna upgraded to $95, Raymond James downgraded), with 85.25% institutional ownership.

- Insiders sold $421.8M (6.8% ownership) amid mixed signals: strong earnings vs. prolonged insider selling and valuation risks.

Nutanix (NTNX) rose 1.13% on September 4, 2025, with a trading volume of $0.22 billion, ranking 473rd in market activity. Institutional investors remain heavily involved in the stock, with Magnetar Financial LLC acquiring 4,568 shares valued at $319,000 in Q1. Tower Research Capital LLC and

Corp also adjusted their positions, with the latter increasing its stake by 2.3% in Q4. The company reported a 19.2% year-over-year revenue growth and an EPS of $0.37, surpassing analyst forecasts.

Analyst activity has been mixed, with Susquehanna upgrading its price target to $95 and

initiating coverage with an "overweight" rating. However, Raymond James downgraded to "market perform" in May. Institutional ownership stands at 85.25%, while insider sales, including shares from CFO Rukmini Sivaraman and CEO Rajiv Ramaswami, have reduced their holdings slightly. Over the past three months, insiders sold $421.8 million worth of stock, representing 6.8% ownership.

The stock currently trades at $18.02 billion market cap, with a P/E ratio of 105.02 and a beta of 0.59. Its 52-week range is $54.66–$83.36, and the 50-day moving average is $72.68. The recent earnings beat and institutional buying suggest short-term confidence, though insider sales and mixed analyst ratings highlight ongoing uncertainty.

Backtest results indicate that Nutanix’s stock price has historically responded positively to institutional purchases and earnings surprises. However, prolonged insider selling and fluctuating analyst ratings may limit long-term momentum. Investors should monitor quarterly guidance and institutional activity for further signals.

Comments



Add a public comment...
No comments

No comments yet